Anaplastic large-cell lymphoma, T-/null-cell type

被引：49

作者：

Jacobsen, Eric ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lymphoma Program, Boston, MA 02115 USA

来源：

ONCOLOGIST | 2006年 / 11卷 / 07期

关键词：

anaplastic large cell lymphoma; lymphomatoid papulosis; cutaneous lymphoma; ALK;

D O I：

10.1634/theoncologist.11-7-831

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Anaplastic large-cell lymphoma, T-/null-cell type (ALCL), is a rare disease that has only been well characterized for two decades. Despite this, the biology of ALCL is better understood than that of many other more common variants of lymphoma. This review focuses on the pathophysiology, clinical presentation, and therapy of ALCL, including stem cell transplantation. In particular, the text emphasizes how novel prognostic features and the evolving understanding of the biology of this disease will influence treatment selection and drug development.

引用

页码：831 / 840

页数：10

共 95 条

[1]

KI-1 POSITIVE LARGE CELL LYMPHOMA - A MORPHOLOGIC AND IMMUNOLOGICAL STUDY OF 19 CASES [J].

AGNARSSON, BA ;

KADIN, ME .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1988, 12 (04) :264-274

[2]

Validating survivin as a cancer therapeutic target [J].

Altieri, DC .

NATURE REVIEWS CANCER, 2003, 3 (01) :46-54

[3]

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].

Ambrosini, G ;

Adida, C ;

Altieri, DC .

NATURE MEDICINE, 1997, 3 (08) :917-921

[4]

B-lymphocyte stimulator (BLyS) is highly expressed in Waldenstrom's macroglobulinemia. [J].

Ansell, SM ;

Grote, DM ;

Ziesmer, SC ;

Witzig, TE ;

Kyle, RA ;

Novak, AJ .

BLOOD, 2004, 104 (11) :630A-630A

[5]

Bartlett NL, 2002, BLOOD, V100, p362A

[6]

Primary and secondary cutaneous CD30+ lymphoproliferative disorders:: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment [J].

Bekkenk, MW ;

Geelen, FAMJ ;

Vader, PCV ;

Heule, F ;

Geerts, ML ;

van Vloten, WA ;

Meijer, CJLM ;

Willemze, R .

BLOOD, 2000, 95 (12) :3653-3661

[7]

ALK-positive lymphoma:: A single disease with a broad spectrum of morphology [J].

Benharroch, D ;

Meguerian-Bedoyan, Z ;

Lamant, L ;

Amin, C ;

Brugières, L ;

Terrier-Lacombe, MJ ;

Haralambieva, E ;

Pulford, K ;

Pileri, S ;

Morris, SW ;

Mason, DY ;

Delsol, G .

BLOOD, 1998, 91 (06) :2076-2084

[8]

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis [J].

Bischof, D ;

Pulford, K ;

Mason, DY ;

Morris, SW .

MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) :2312-2325

[9]

The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma [J].

Borchmann, P ;

Treml, JF ;

Hansen, H ;

Gottstein, C ;

Schnell, R ;

Staak, O ;

Zhang, HF ;

Davis, T ;

Keler, T ;

Diehl, V ;

Graziano, RF ;

Engert, A .

BLOOD, 2003, 102 (10) :3737-3742

[10]

Bordon Victoria, 2005, Haematologica, V90, pECR19

← 1 2 3 4 5 6 7 8 9 10 →